Clinical Trial Update: Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors [NA]

View source ↗

Summary

A clinical trial update examining the genetic landscape of women with metastatic ovarian cancer before and during PARP inhibitor therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• PARP inhibitors

Snippet

Sponsor: European Institute of Oncology | Conditions: Leukemia, Myeloid, Acute, Myeloid Dysplasia | NA | Status: RECRUITING